Evidence map›Paper›PMID 19293389›Full record

ArticleThe Journal of pharmacology and experimental therapeutics2009

Essential role of the 90-kilodalton heat shock protein in mediating nongenomic estrogen signaling in coronary artery smooth muscle.

Guichun Han, Handong Ma, Rajesh Chintala, David J R Fulton, Scott A Barman, Richard E White

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of pharmacology and experimental therapeutics, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. HDAC6 regulates glucocorticoid receptor signaling in serotonin pathways with critical impact on stress resilience.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2012
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Guichun HanDepartment of Pharmacology and Toxicology, Medical College of Georgia, Augusta, Georgia, USA. ghan@mcg.edu
Handong Ma
Rajesh Chintala
David J R Fulton
Scott A Barman
Richard E White
Augusta University Health · USInstitute of Pharmacology · CZAugusta University · US

Funding

PKC Signaling in cAMP-Induced Pulmonary VasodilationR01HL068026 · NHLBI · MEDICAL COLLEGE OF GEORGIA (MCG) · PI BARMAN, SCOTT A · 2001 to 2010
$2.3M
NONGENOMIC MECHANISMS OF ANDROGENS IN THE VASCULAR WALLR01HL080402 · NHLBI · TEXAS A&M AGRILIFE RESEARCH · PI STALLONE, JOHN NICHOLAS · 2006 to 2009
$1.4M
Estrogen dual effects on coronary arteriesR01HL073890 · NHLBI · MEDICAL COLLEGE OF GEORGIA (MCG) · PI WHITE, RICHARD E · 2005 to 2008
$1.3M
Regulation of eNOS by Subcellular TargetingR01HL074279 · NHLBI · MEDICAL COLLEGE OF GEORGIA (MCG) · PI FULTON, DAVID J · 2003 to 2006
$1.2M
NHLBI NIH HHS HL068026NHLBI NIH HHS HL073890NHLBI NIH HHS HL074279NHLBI NIH HHS HL080402
6 · The paper itself

Abstract

Under normal physiological conditions, estrogen is a coronary vasodilator, and this response involves production of NO from endothelial cells. In addition, estrogen also stimulates NO production in coronary artery smooth muscle (CASM); however, the molecular basis for this nongenomic effect of estrogen is unclear. The purpose of this study was to investigate a potential role for the 90-kDa heat shock protein (Hsp90) in estrogen-stimulated neuronal nitric-oxide synthase (nNOS) activity in coronary artery smooth muscle. 17Beta-estradiol produced a concentration-dependent relaxation of endothelium-denuded porcine coronary arteries in vitro, and this response was attenuated by inhibiting Hsp90 function with 1 microM geldanamycin (GA) or 100 microg/ml radicicol (RAD). These inhibitors also prevented estrogen-stimulated NO production in human CASM cells and reversed the stimulatory effect of estrogen on calcium-activated potassium (BK(Ca)) channels. These functional studies indicated a role for Hsp90 in coupling estrogen receptor activation to NOS stimulation in CASM. Furthermore, coimmunoprecipitation studies demonstrated that estrogen stimulates bimolecular interaction of immunoprecipitated nNOS with Hsp90 and that either GA or RAD could inhibit this association. Blocking estrogen receptors with ICI182780 (fulvestrant) also prevented this association. These findings indicate an essential role for Hsp90 in nongenomic estrogen signaling in CASM and further suggest that Hsp90 might represent a prospective therapeutic target to enhance estrogen-stimulated cardiovascular protection.

Indexed as

AnimalsBenzoquinonesCells, CulturedCoronary VesselsEnzyme InhibitorsEstradiolEstrogen AntagonistsEstrogensFulvestrantHSP90 Heat-Shock ProteinsHumansLactams, MacrocyclicLarge-Conductance Calcium-Activated Potassium ChannelsMacrolidesMuscle, Smooth, VascularMyocytes, Smooth MuscleBenzoquinonesEnzyme InhibitorsEstradiolEstrogen AntagonistsEstrogensFulvestrantgeldanamycinHSP90 Heat-Shock ProteinsLactams, MacrocyclicLarge-Conductance Calcium-Activated Potassium ChannelsMacrolidesmonordenNG-Nitroarginine Methyl EsterNitric OxideNitric Oxide Synthase Type I

Identifiers

PMID19293389
PMCPMC2683768
OpenAlexW2153474081

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.